Men over 40 with BRCA2 gene fault ‘should get regular PSA screening’ 05 Nov 2019 Guidelines should change so that all men over the age of 40 with faults in the BRCA2 gene should be offered regular PSA testing to detect early signs of prostate cancer, experts are urging. Find out more Show/Hide
ICR and The Royal Marsden form part of new radiotherapy research network after receiving major new funding 04 Nov 2019 A new radiotherapy network will unite seven centres across the UK to pioneer the use of the latest technologies, creating a global hub for radiotherapy research. Find out more Show/Hide
ICR celebrates major donation from CRIS Cancer Foundation at exclusive supporter event 24 Oct 2019 At our recent Discovery Club event, members thanked CRIS Cancer Foundation for their donation of £1.4 million to support immunotherapy research at the ICR. Find out more Show/Hide
ICR researchers working with Imperial College London to investigate medical cannabis for cancer and acute pain 15 Oct 2019
New Athena SWAN Silver Award recognises ICR’s work on diversity and access to opportunities 10 Oct 2019
ICR forms collaboration with AI drug discovery company to develop new possible treatments in rare childhood cancer DIPG 03 Oct 2019
ESMO 2019: Breast and ovarian cancer drug outperforms targeted hormone therapy in some men with advanced prostate cancer 30 Sep 2019